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Abstract  
AIM: The aim of the study was to present our results about immunological and immunogenetic 
investigations in children with autistic disorder in Republic of Macedonia. 
METHODS: Infantile autism was diagnosed by DSM-IV and ICD-10 criteria. Plasma samples 
were collected from 35 autistic subjects, and their 21 siblings (biological brothers and sisters) 
who served as healthy controls. Plasma samples were separated by centrifugation and stored at 
–20C until the determination. Plasma immunoglobulin classes (IgM, IgA, IgG) and subclasses 
(IgG1, IgG2, IgG3, IgG4) were determined using a nephelometer Analyzer. Specific IgA and IgG 
antibodies against some food allergens, as well as total IgE have been determined with 
automated immunofluorescent device with solid phase - UniCAP 100 (AmershamBiosciences). 
HLA DNA typing of class I genes was performed using a Reverse Line Strip method (RLS), and 
the Sequencing Based Typing method (SBT) was used for typing of class II genes. 
RESULTS: Children with autism had significantly higher plasma concentrations of IgG4 
(p<0.001) compared to their siblings (healthy brothers or sisters). IgE specific antibodies, as 
well as plasma concentration of total IgE were statistically significant higher in plasma of 
participants with autism. Multiple comparisons for the IgA variable have shown statistically 
significant differences between children with autistic disorder from the fathers and mothers (p < 
0.001), and healthy brothers and sisters from the fathers and mothers (p < 0.001). Our results 
showed significantly increased frequencies of HLA-C*03 (OR = 2.74*; 
2
= 4.68; p = 0.03), and 
HLA-DRB1*01 (OR = 3.10*; 
2
= 6.26; p = 0.012) alleles in autistic patients when compared to 
the controls. 
CONCLUSION: Children with autism have increased plasma concentration of 
immunoglobulines. Our results demonstrate an association of HLA-C*03 and HLA-DRB1*01 
alleles with Macedonian autistic patients. Comparison between healthy children and children 
with autistic disorder from the same family should be tested for immunoglobulin classes and 
subclasses in order to avoid differences between generations. 
 
 
 
 
 
 
Introduction 
  
Autism is a severe neurodevelopmental 
disorder characterized by a triad of impairments in 
reciprocal social interaction, verbal and nonverbal 
communication, and a pattern of repetitive 
stereotyped activities, behaviors, and interests [1]. 
A number of factors have been implicated in 
the pathogenesis of autism including genetic [2], 
environmental [3], and immunological factors [4]. 
There are strong lines of evidence to suggest that the 
immune system plays an important role in the 
pathogenesis of autism. These include changes in 
lymphocyte subsets [5], alteration in serum 
concentration of immunoglobulin classes and 
subclasses [6, 7] and cytokine production [8], 
presence of autoantibodies to neural antigens [9], 
increased frequency of the C4b null allele [10], and 
linkage to some immune response genes [11]. 
Abnormal immunoglobulins (low IgA, 
increased IgE), decreased natural killer cells and 
other T-cell abnormalities may reflect the 
“disregulation” of the immune system in persons with 
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autism [12]. The alteration in the immune system may 
also occur in parallel to changes in the developing 
central nervous system (CNS), and both may have the 
same aetiologies that underlie autism [9, 13-15]. 
Therefore the immune abnormalities would appear to 
be causative [16]. 
The aim of the study was to present our 
results about immunological and immunogenetic 
investigations in children with autistic disorder in 
Republic of Macedonia.  
 
 
Material and Methods 
 
Subjects 
Infantile autistic disorder was diagnosed by 
DSM-IV (American Psychiatric Association, 1994) and 
ICD-10 (World Health Organization, 1992) criteria. 
Thirty-five Macedonian patients (25 boys and 10 girls) 
with autistic disorder were studied, as well as 21 of 
their siblings (7 boys, and 14 girls). The mean age 
was 11  5.90 years with minimum 4, and maximum 
25 years old. The survey was realized on the territory 
of the Republic of Macedonia. 
 
 Immunoglobulin determination 
Blood samples were separated by 
centrifugation, and stored at - 20C until the 
determination. Serum immunoglobulin classes (IgA, 
IgG, and IgM) and subclasses (IgG1, IgG2, IgG3, and 
IgG4) were determined immunonephelometricallly by 
an automated Nephelometer Analyzer BN-100 (Dade-
Behring, Vienna, Austria) as anonymous samples. 
 
Determination of Specific Food Antibodies 
Ten milliliters of venous blood was drawn 
from each donor by the standard venipuncture in a 
vacutainer with EDTA(K3) after parental consent. At 
the time of blood drawing, none of autistic children 
were receiving any prescription medication or 
antipsychotic drug. Plasma samples were separated 
by centrifugation and stored at –20
0
C till the 
determination. Specific antibodies, as well as total IgE 
have been determined with automated 
immunofluorescent device with solid phase - UniCAP 
100 (AmershamBiosciences). The determinations 
were performed at the Institute of Immunobiology and 
Human Genetics at the Faculty of Medicine in Skopje. 
External quality control of total serum IgE and allergen 
specific IgE was performed by United Kingdom 
National External Quality Assessment Service for 
Immunology and Immunochemistry (UKNEQAS).  
 
Genotyping of HLA 
Genomic DNA was extracted from whole 
blood using standard proteinase K digestion method 
followed by salting-out extraction and ethanol 
precipitation [17]. HLA DNA typing of class I genes 
was performed using a Reverse Line Strip method 
(RLS), and the Sequencing Based Typing method 
(SBT) was used for typing of class II genes [18-20]. 
Statistical analysis was performed with Arlequin 
v.2.000 software kindly provided by Excoffier and 
Slatkin [21, 22]. In summary, this program calculated 
HLA-A, -C, -B, and –DRB1 allele frequencies, Hardy-
Weinberg equilibrium and the linkage disequilibrium 
between two alleles at two different loci. The number 
of autistic subjects and controls from Macedonian 
population positive for an allele or a haplotype were 
compared. The Odds Ratio (OR) expressed the 
strength of the statistical association between the 
syndrome and genetic markers. The statistical 
significance was examined by Chi-square test. 
 
Statistics 
The research data have been stored, 
classified and processed with standard statistical 
program Statgraphics Plus for Windows 2.1 version. 
Standardized skewness and stardized kurtosis were 
used to determine whether the samples come from 
normal distribution. Values of these statistics outside 
the range of -2 to +2 indicate significant departure 
from normality. Kolmogorov-Smirnov test was used to 
compare the distribution of the two samples. This test 
is performed by computing the maximum distance 
between the cumulative distributions of the two 
samples. P values of 0.05 or less were considered 
significant.  
 
 
Results 
 
Immunological findings in autistic disorder 
Plasma concentration of IgM in autistic 
chlidren was significantly higher (p = 0.031) in 
comparison with their healthy brothers or sisters (1.36 
 0.31 g/L and 1.20  0.15 g/L, respectively). Plasma 
concentration of total IgG in autistic children was 
significantly higher (p = 0.023) in comparison with 
their siblings (13.14  1.27 g/L and 12.39  0.96 g/L, 
respectively). The mean value of plasma 
concentration for IgG4 in autistic group was 0.69  
0.14 g/L, and in control group 0.45  0.14 g/L, and 
was significantly increased in autistic patients (p < 
0.001). Plasma concentrations of immunoglobulin 
classes and subclasses were similar in autistic 
children and their healthy brothers or sisters for IgA, 
IgG1, IgG2, and IgG3 (Table 1). 
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Table 1: Age and plasma concentration of immunoglobulin 
classes and subclasses in children with autism and their 
healthy broders or sisters in the Republic of Macedonia. Data 
are expressed as means ± SD [23]. 
Parameters Autistic children (n=35) Healthy brothers or sisters (n=21) p* 
Age (year) 10.145.81 13.146.45 0.078 
Immunoglobulins (g/L) 
IgA 1.630.33 1.520.30 0.217 
IgM 1.360.31 1.200.15 0.031 
IgG 13.141.27 12.390.96 0.023 
IgG1 8.450.82 8.090.60 0.086 
IgG2 2.440.38 2.340.52 0.441 
IgG3 0.460.07 0.450.09 0.644 
IgG4 0.690.14 0.450.14 <0.001 
*Student’s t test. 
 
Distribution of immunoglobulin classes and 
subclasses (IgA, IgM, IgG, IgG1, IgG2, IgG3, and 
IgG4) in probands, fathers and mothers are presented 
on the matrix plot, where the one-dimensional 
distribution is shown by diagonal and two-dimensional 
distribution by symmetrical matrix (Figure 1).  
In the probands (n = 28) we can see that the 
individual classes and subclasses correlate between 
each other, there is very strong positive correlation 
between IgG and IgG1, and smaller correlation 
between the rest of variables. We can see one 
extreme value of IgA (4.133 g/L), and one of IgG4 
(1.999 g/L), which are probably biological variations 
(Fig. 1.A). In the fathers (n = 24) we can see good 
correlation between the IgG, IgG1, IgG3, and IgG4, 
but also the other variables correlate to the some 
degree. We can see one extreme value of IgG, IgG1, 
IgG3, and IgG4 in the very same father, and one 
extreme value of IgM (Fig. 1B). In the mothers (n = 
28) we can see good correlation between the IgG, 
IgG1, IgG2 and IgG3, but the rest of variables are also 
with good correlation. There are no extreme values of 
immunoglobulin classes and subclasses in the 
mothers (Fig. 1.C). 
Combination of distribution of immunoglobulin 
classes and subclasses (IgA, IgM, IgG, IgG1, IgG2, 
IgG3, and IgG4) between probands and their parents 
(fathers and mothers) are presented on the matrix 
plot, where the distribution of probands is shown 
horizontally, and distribution of parent is shown 
vertically. We can see that the distribution of 
immunoglobulin classes and subclasses between 
probands and their fathers (n = 24), as well as with 
their mothers (n = 28) are dispersed, without any 
correlation (Figure 2). 
Correlations of immunoglobulin classes and 
subclasses (IgA, IgM, IgG, IgG1, IgG2, IgG3, and 
IgG4) in all probands, fathers and mothers are 
presented on the matrix plot (Figure 3). We can see 
high positive correlation between IgG and IgG1, a little 
bit smaller positive correlation between IgG and IgG2, 
as well between IgG and IgG3. We can see that IgA 
and IgM do not correlate between themselves. 
 
 
 
 
A. Probands 
Matrix Plot (Autizam_podaci_ispr 38v*64c)
IgA
IgM
IgG
IgG1
IgG2
IgG3
IgG4
 
B. Fathers 
Matrix Plot (Autizam_podaci_ispr 38v*64c)
IgA_F
IgM_F
IgG_F
IgG1_F
IgG2_F
IgG3_F
IgG4_F
 
C. Mothers 
Matrix Plot (Autizam_podaci_ispr 38v*64c)
IgA_M
IgM_M
IgG_M
IgG1_M
IgG2_M
IgG3_M
IgG4_M
 
 
Figure 1: Distribution of immunoglobulin classes and subclasses 
(IgA, IgM, IgG, IgG1, IgG2, IgG3, and IgG4) in probands, fathers 
and mothers.  
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Correlation matrix all groups (n=98) 
Correlations (Autizam_zajedno 39v*150c)
IgA
IgM
IgG
IgG1
IgG2
IgG3
IgG4
All Groups
 
 
Figure 2: Correlations of immunoglobulin classes and subclasses 
(IgA, IgM, IgG, IgG1, IgG2, IgG3, and IgG4) in all probands, fathers 
and mothers presented on the matrix plot. 
 
Seven variables (IgA, IgM, IgG, IgG1, IgG2, 
IgG3, and IgG4) entered into factorial multivariate 
analysis of variance (MANOVA) with two factors, sex 
(male/female), and three groups regarding autistic 
disorder (person with autistic disorder, father/mother 
of a person with autistic disorder, and brother/sister), 
giving altogether six groups. Post hoc multiple 
comparisons with Tukey HSD test were made to 
reveal statistically significant pairs of groups for the 
IgA variable. We can see statistically significant 
differences between three pairs: male autistic from the 
fathers (p = 0.001), male autistic from the mothers (p 
= 0.008), as well as healthy sisters from the fathers (p 
= 0.011) (Table 2). 
 
Table 2: Multivariate analysis of variance (MANOVA) for 6 
variables, factorial model for sex (male/female), and group 
membership regarding autistic disorder (person with autistic 
disorder, father/mother of a person with autistic disorder, and 
brother/sister) [24]. 
Turkey HSD test, variable IgA for all autistic disorder (Probabilities for post hoc tests; error: 
between MS = 0.827, df = 92.000) 
Sex*Family 
member 
Male 
autistic 
1.374 
Father 
 
2.531 
Healthy 
brother 
1.562 
Female 
autistic 
1.505 
Mother 
 
2.330 
Healthy 
sister 
1.472 
Male autistic       
Father 0.001*      
Healthy 
brother 
0.998 0.196     
Female 
autistic 
0.999 0.076 0.999    
Mother 0.008* 0.971 0.427 0.224   
Healthy sister 0.999 0.011* 0.999 1.000 0.056  
*, Statistically significant. 
 
Mean plasma concentration of total IgE in 
participants with autistic disorder was more than 
seven times higher (246.312 kU/L) than in their 
siblings (37.209 kU/L) with standard deviation twice 
bigger than average value, and standardized 
skewness and kurtosis far above normal distribution.  
Probands and Fathers (n=24) 
Matrix Plot (Autizam_podaci_ispr 38v*64c)
IgA IgM IgG IgG1 IgG2 IgG3 IgG4
IgA_F
IgM_F
IgG_F
IgG1_F
IgG2_F
IgG3_F
IgG4_F
 
Probands and Mothers (n=28) 
Matrix Plot (Autizam_podaci_ispr 38v*64c)
IgA IgM IgG IgG1 IgG2 IgG3 IgG4
IgA_M
IgM_M
IgG_M
IgG1_M
IgG2_M
IgG3_M
IgG4_M
 
 
Figure 3: Combination of distribution of immunoglobulin classes and 
subclasses (IgA, IgM, IgG, IgG1, IgG2, IgG3, and IgG4) between 
probands and their parents (fathers and mothers) presented on the 
matrix plot. 
 
Statistical analysis with Kolmogorov-Smirnov 
test was significant (p = 0.044) (see Table 3). 
 
Table 3: Plasma concentration of total IgE, and logarithmic 
transformation of total IgE (kU/L) in the participants with 
autistic disorder (n = 35) and their siblings (n = 21) in the 
Republic of Macedonia [25]. 
 
Allergen Group Average 
Standard 
deviation 
Standardized 
skewness 
Standardized 
kurtosis 
p 
Total IgE 
Autistic 
disorder 
246.31 639.23 11.54& 30.33& 
0.044 
Siblings 37.21 33.50 2.54& 1.20 
Log total 
IgE 
Autistic 
disorder 
1.79 0.67 1.50 0.45 
0.044 
Siblings 1.38 0.46 -1.12 0.06 
&, Specific departure from normal distribution; p, statistically significant difference between 
the two distributions (participants with autistic disorder and siblings) tested by Kolmogorov-
Smirnov test. 
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Immunogenetic findings in autistic 
disorder 
 Eleven different HLA-C alleles have been 
found in autistic group from which the most frequent 
were C*12 (20%), C*07 (17.1%) and C*03 (12.9%). 
Statistical analysis with Chi-square test have shown 
significantly higher frequency of C*03 allele, which 
can be found 2.5 times more in autistic patients than 
in healthy population (OR = 2.74; 
2 
= 4.68; p = 0.03;) 
(Table 4). 
Table 4: HLA-C allele frequencies in Macedonian autistic 
patients and controls [26]. 
HLA-C allele Allele frequency 
N (%) 
controls 
Allele frequency 
N (%) 
autism 
Odds ratio 
OR 

2
 p-value 
C*01  9 (4.6) 2 (2.9) 0.61 0.08 NS 
C*02            19 (9.7) 6 (8.6) 0.87 0.08 NS 
C*03            10 (5.1) 9 (12.9) 2.74* 4.68 0.03 
C*04            27 (13.8) 6 (8.6) 0.59 1.29 NS 
C*05            8 (4.1) 0 2.71 1.71 NS 
C*06            8 (4.1) 6 (8.6) 2.20 2.09 NS 
C*07            53 (27.0) 12 (17.1) 0.56 2.74 NS 
C*08            1 (0.5) 3 (4.3) 8.73 2.74 NS 
C*12            32 (16.3) 14 (20.0) 1.28 0.49 NS 
C*14            8 (4.1) 5 (7.1) 1.81 1.04 NS 
C*15            15 (7.6) 5 (7.1) 0.93 0.02 NS 
C*16            3 (1.5) 2 (2.9) 1.89 0.04 NS 
C*17            3 (1.5) 0 0 0.15 NS 
Total 196 (100.0) 70 (100.0)    
 
 Data from class II, specifically alleles from 
DRB1 locus are shown in Table 5. Ten different 
alleles have been found in autistic patients, with most 
frequency of DRB1*11 (21.4%), DRB1*01 (14.3%), 
DRB1*15 (12.9%) and DRB1*16 (12.9%). Significantly 
higher frequency of DRB1*01 allele compared to 
control subjects have been found (OR = 3.10*; 
2 
= 
6.26; p = 0.012). 
Table 5: HLA-DRB1 allele frequencies in Macedonian autistic 
patients and controls [26]. 
HLA-DRB1 
allele 
Allele frequency 
N (%) 
Controls 
Allele frequency 
N (%) 
autism 
Odds ratio 
OR 

2
 p-value 
DRB1*01            10 (5.1) 10 (14.3) 3.10* 6.26 0.012 
DRB1*03            14 (7.1) 5 (7.1) 1.00 0.00 NS 
DRB1*04            15 (7.6) 3 (4.3) 0.54 0.47 NS 
DRB1*07            13 (6.6) 4 (5.7) 0.85 0.00 NS 
DRB1*08            6 (3.1) 0 0 1.02 NS 
DRB1*09            1 (0.5) 0 0 0.29 NS 
DRB1*10            0 2 (2.9) 0 2.46 NS 
DRB1*11            47 (24.0) 15 (21.4) 0.86 0.19 NS 
DRB1*12            3 (1.5) 0 0 0.15 NS 
DRB1*13            18 (9.2) 8 (11.4) 1.28 0.29 NS 
DRB1*14            6 (3.1) 5 (7.1) 2.44 2.17 NS 
DRB1*15            25 (12.7) 9 (12.9) 1.01 0.00 NS 
DRB1*16            38 (19.4) 9 (12.9) 0.61 1.51 NS 
Total 196 (100.0) 70 (100.0)    
 
 
Discussion 
 
 Our study has shown that children with autism 
had significantly increased values of IgG4 compared 
with their healthy siblings. This could be a 
consequence of enhanced autoimmunity and/or 
allergy in persons with autism. When autistic males 
were compared with their healthy brothers and autistic 
females with their healthy sisters, there was a 
statistical increase in plasma concentration of IgG1. In 
addition, autistic females had significantly higher 
plasma concentration of total IgG in comparison with 
their healthy sisters. These results differ from the 
cumulative data for all the children with autism. 
Studies of immunoglobulins or antibodies-
titers in autistic patients have yielded contradictory 
results so far. Some investigators found no abnormal 
increase in immunoglobulin levels in either serum or 
cerebrospinal fluid [27]. Ferrari et al [28] reported 
elevated IgG, IgM, and IgA antibody-titers in the 
serum of autistic patients, although significance was 
only reached for IgG titers. In contrast, in the study of 
Gupta et al [29], 20% of children with autism had a 
deficiency of IgA and 8% lacked it completely, and 
20% had an IgG subclass deficiency. Serum levels of 
IgM and IgE were increased in 56% of patients, and 
high levels of IgG1 subclass were found in only 2 
patients. Comparing our results with those of Gupta et 
al [29], we found significantly higher concentration of 
IgA, IgG1, IgG2, and IgG4. In 8 of 35 persons with 
autism (23%) we found lower levels of IgA compared 
to the normal values (data are not shown). Wareen et 
al [12] reported that 20% of individuals with autism 
had low serum IgA. Thus, IgA deficiency is more 
common in autism than in normal Caucasian 
population. 
Low levels of IgG, IgA, and IgM and 
subfractions of IgG were found by Zimmerman et al 
[6]. They reported several autistic patients, positive for 
antinuclear antibodies, characteristic for autoimmune 
disorders like lupus or rheumatoid arthritis [6]. 
Croonenberghs et al [7], found increased serum 
concentrations of IgG, IgG2, and IgG4. They reported 
positive correlations between social problems and 
total serum proteins and serum gamma globulins, as 
well as between the withdrawal of the symptoms and 
total serum proteins and serum albumin and IgG. 
 Our study showed that statistically significant 
differences found with factorial multivariate analysis of 
variance with two factors, sex (male/female), and 
three groups regarding autistic disorder (person with 
autistic disorder, father/mother of a person with 
autistic disorder, and brother/sister) belongs to IgA, 
IgM, and IgG2 variables. Post hoc multiple 
comparisons with Tukey HSD reveal statistically 
significant pairs of groups for the IgA variable. We 
found statistically significant differences between 
three pairs: male autistic from the fathers, female 
autistic from the mothers, as well as healthy sisters 
from the fathers. The results should be interpreted 
very carefully. We can interpret that IgA, IgM, and 
IgG2 are connected somehow with the autistic 
disorder in the male and female persons, but we 
cannot interpret connection of healthy sisters with the 
fathers. There is also possibility that found differences 
are rather between generations (older and younger 
generations), and/or because of the small number of 
the groups (there are only 8 female with autistic 
disorder, and only 7 healthy brothers) [23]. 
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 We found that mean plasma concentration of 
total IgE in participants with autistic disorder was more 
than seven times higher than in their siblings. We 
examined specific IgA, IgG, and IgE antibodies to food 
antigens in 35 participants with autistic disorder and 
21 of their siblings in the Republic of Macedonia. We 
found statistically significant higher plasma 
concentration of IgA antibodies against alpha-
lactalbumin, beta-lactoglobulin, casein, and gliadin in 
the children with autistic disorder. Plasma 
concentrations of IgG antibodies against alpha-
lactalbumin, beta-lactoglobulin, and casein in 
participants with autistic disorder were significantly 
higher. IgE-specific antibodies (alpha-lactalbumin, 
beta-lactoglobulin, casein, and gluten), as well as 
plasma concentration of total IgE, also were 
statistically significantly higher in the participants with 
autistic disorder. Gender differences were found for 
select IgA, IgG, and IgE (but not for total IgE) food-
specific antibodies (kU/L) in the participants with 
autistic disorder and their siblings [25]. These results 
support the idea that in individuals with predisposing 
HLA molecules, dietary peptides bind to 
aminopeptidases and possibly other enzymes and 
induce antibodies to dietary peptides and tissue 
antigens. 
 The strongest evidence for a link between 
autism and immune system comes from 
immunogenetic studies. HLA antigens are involved in 
the qualitative and quantitative aspects of immune 
system response. If autism is in some cases the result 
of immune system attack, then particular HLA 
antigens might be involved as a sufficient or 
predisposing factor [30]. The immunogenetic profile of 
the Macedonian population represented by HLA 
genes is published for HLA-A, -B, -DR, -DQ allele 
frequencies [31], for  HLA-DRB1, DRB3/4/5 and 
DQB1 polymorphism [32], for HLA-A and HLA-B 
epidemiology [33], for high-resolution sequence-based 
method for direct HLA-DRB1 typing [34], for 
ambiguous allele combinations at the allele group 
level of HLA-A, -C and -B loci [35], and for HLA-DQB1 
typing [36]. Our results showed significantly increased 
frequencies of HLA-C*03 and HLA-DRB1*01 alleles in 
autistic patients when compared to the controls. 
Rogers et al. in 1999 have tested a 
hypothesis about a role for the HLA loci in the genetic 
susceptibility to autism. They did that by linkage 
analysis using genetic marker loci in the HLA region 
on chromosome 6p in multiplex families with autism. 
They have examined sharing of alleles identical by 
descent in 97 affected sib pairs from 90 families. Their 
results demonstrated no deviation from null 
expectation of 50% sharing of alleles in that region. 
Thus, it was unlikely that loci in that region contribute 
to the genetic etiology of autism to any significant 
extent in our families [37]. 
Our results for the connection between class I 
and II alleles in persons with autism in the 
Macedonian population are different from those 
published in the literature. While Warren R. et al. [38] 
found association with alleles DRB1*0401, 
DRB1*0101 and DRB1*0701, we found association 
with DRB1*01 alleles. His team found association with 
HLA-B* allele [10], which we couldn’t register in the 
Macedonian sample of children with autism. We 
detected increased frequency of the HLA-C*03 allele 
and association with autism, a data we did not 
succeed t find in the literature. These differences 
could be due to a different genetic structure of the 
Macedonian population or to different association of 
the HLA alleles with the autism in the Macedonian 
population. Additional examinations of the HLA alleles 
in the families with autism are necessary to get more 
answers about the Macedonian population. 
 Several investigations of transmission 
disequilibrium (TDT) for HLA in families with autism 
were investigated. Significant transmission 
disequilibrium for HLA-DR4 was seen (odds ratio, 
4.67; 95% confidence interval, 1.34-16.24; P = 0.008) 
for transmissions from maternal grandparents to 
mothers of probands, supporting a role for HLA-DR4 
as an autism risk factor acting in mothers during 
pregnancy. Transmission disequilibrium was not seen 
for HLA-DR4 transmissions from parents to probands 
or from mothers to probands. The HLA-DR4 gene 
may act in mothers of children with autism during 
pregnancy to contribute to autism in their offspring 
[39]. The transmission disequilibrium test indicated 
that the ASD probands inherited the DR4 allele more 
frequently than expected (p = 0.026) from the fathers. 
The TDT also revealed that fewer DR13 alleles than 
expected were inherited from the mother by ASD 
probands (p = 0.006) [40]. The transmission 
disequilibrium test for the A2 allele revealed an 
increased frequency of inheritance for autistic children 
(p = 0.033). There were no significant associations of 
autism with HLA-B alleles; however, the A2-B44 and 
A2-B51 haplotypes were two times more frequent in 
autistic subjects [41].  
 Killer-cell immunoglobulin-like receptor (KIR) 
proteins are expressed on natural killer (NK) cells and 
appear important in innate and adaptive immunity. 
There are about 14 KIR genes on chromosome 
19q13.4, composed of those that inhibit and those that 
activate NK cell killing. Haplotypes have different 
combinations of these genes meaning that not all 
genes are present in a subject. There are two main 
classes of cognate human leukocyte antigen (HLA) 
ligands (HLABw4 and HLA-C1/C2) that bind to the 
inhibitory/activating receptors. As a general rule, the 
inhibitory state is maintained except when virally 
infected or tumor cells are encountered; however, 
both increased activation and inhibition states have 
been associated with susceptibility and protection 
against numerous disease states including cancer, 
arthritis, and psoriasis. Utilizing DNA from 158 
Caucasian subjects with autism and 176 KIR control 
subjects it was shown for the first time a highly 
significant increase in four activating KIR genes 
Spiroski. Immunological and Immunogenetic Changes in Children with Autistic Disorder 
_______________________________________________________________________________________________________________________________ 
_______________________________________________________________________________________________________________________________ 
SEE J Immunol. 2015 Feb 08; 2015:20003.                                                                                                                                                                                       7 
 
(2DS5, 3DS1, 2DS1 and 2DS4) as measured by chi 
square values and odds ratios. In addition, published 
data suggests a highly significant increase in the 
activating KIR gene 2DS1 and its cognate HLA-C2 
ligand (2DS1+C2; p=0.00003 [Odds Ratio=2.87]). This 
information ties together two major immune gene 
complexes, the Human Leukocyte Complex and the 
Leukocyte Receptor Complex, and may partially 
explain immune abnormalities observed in many 
subjects with autism [42]. Activating KIR/HLA 
complexes (aKIR/HLA) were recently suggested to 
prevail in children with autism spectrum disorders 
(ASD), a neurodevelopmental syndrome character-
rized by brain and behavioral abnormalities and 
associated with a degree of inflammation. It was 
verified whether such findings could be confirmed by 
analyzing two sample cohorts of Sardinian and 
continental Italian ASD children and their mothers. 
Results showed that aKIR/HLA are increased 
whereas inhibitory KIR/HLA complexes are reduced in 
ASD children in two sample cohorts of Sardinian and 
continental Italian ASD children and their mothers. 
KIR and HLA molecules are expressed by placental 
cells and by the trophoblast and their interactions 
result in immune activation and influence fetal, as well 
as central nervous system development and plasticity. 
Published data suggest that in utero KIR/HLA immune 
interactions favor immune activation in ASD and this 
may play a role in the pathogenesis of the disease 
[43]. 
 In conclusion, we can say that children with 
autism have increased plasma concentration of 
immunoglobulines. Multiple comparisons for the IgA 
variable have shown statistically significant 
differences between children with autistic disorder 
from the fathers and mothers (p < 0.001), and healthy 
brothers and sisters from the fathers and mothers (p < 
0.001). Our results demonstrate an association of 
HLA-C*03 and HLA-DRB1*01 alleles with Macedonian 
autistic patients.  
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